Michael Dudley
Fondateur chez Rempex Pharmaceuticals, Inc.
Provenance du réseau au premier degré de Michael Dudley
Entité | Type d'entité | Industrie | |
---|---|---|---|
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Qpex Biopharma, Inc.
Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Qpex Biopharma, Inc. develops a pipeline of agents addressing critical needs for the treatment of infectious diseases in the inpatient and outpatient settings. The company is headquartered in San Diego, CA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Michael Dudley via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
MPEX Pharmaceuticals, Inc.
MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
OTONOMY | Biotechnology | Compliance Officer Director/Board Member Chief Operating Officer | |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor Private Equity Investor | |
Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal | |
Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
San Diego State University | College/University | Undergraduate Degree Undergraduate Degree | |
HARBOR DIVERSIFIED, INC. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Outpost Medicine, Inc.
Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Outpost Medicine LLC develops therapeutics for the treatment of urologic and gynecologic disorders. The company was founded by David Socks and Tachi Yamada in 2016 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
FUSN PHAR | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PrinJohnson BioPharm, Inc.
PrinJohnson BioPharm, Inc. Pharmaceuticals: MajorHealth Technology PrinJohnson BioPharm, Inc. focuses on the development and sale of generic pharmaceuticals. The company is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | Director/Board Member | |
DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
BELLUS HEALTH | Pharmaceuticals: Major | Director/Board Member | |
Perfuse Therapeutics, Inc.
Perfuse Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Perfuse Therapeutics, Inc. operates as biotechnology company that focuses on retinal perfusion. The company was founded by Sevgi Gurkan in 2018 and is headquartered in San Francisco,CA. | Miscellaneous Commercial Services | Director/Board Member | |
GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member | |
SONENDO, INC. | Medical Specialties | Director/Board Member | |
INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Arius, Inc.
Arius, Inc. Engineering & ConstructionIndustrial Services Arius, Inc. manufactures electrical testing equipment. The company was founded in 1999 and is headquartered in Frederick, MD. | Engineering & Construction | Director/Board Member | |
Gennao Bio, Inc.
Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services ADARx Pharmaceuticals, Inc. operates as RNA base-editing company. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Portfolio Manager-Equities | |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Biotechnology | Director/Board Member | |
INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
OnCusp Therapeutics6
OnCusp Therapeutics6 Miscellaneous Commercial ServicesCommercial Services OnCusp Therapeutics is a biotechnology company based in New York, NY and has subsidiaries in China. OnCusp Therapeutics specializes in developing preclinical assets to clinical proof of concept and then partnering out for commercialization in the field of oncology therapeutics. The company is committed to accelerating the advancement of oncology assets by leveraging its deep translational and clinical development expertise. OnCusp Therapeutics is backed by prominent investors including Sequoia Capital, Biotrack Capital, Oriza Seed Capital, and AIHC Capital. The company was founded in 2021 by Andy Fu, Bing Yuan, and Eric Slosberg, with Bing Yuan serving as the CEO since then. | Miscellaneous Commercial Services | Director/Board Member | |
Upstream Bio, Inc.
Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Medical Specialties | Corporate Officer/Principal | |
University of California San Diego | College/University | Undergraduate Degree | |
Tarsus China Ltd. | Director/Board Member | ||
Surgical Specialties Corp.
Surgical Specialties Corp. Medical SpecialtiesHealth Technology Surgical Specialties Corp. manufactures medical products. It specializes in designing and manufacturing of surgical knives and wound closure products. The firm offers suture needles, sutures, microsurgical cutting instruments, eye garters, and ophthalmic cannulas. The company is headquartered in Westwood, MA. | Medical Specialties | Chairman | |
German Medical Technology Co., Ltd.
German Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology German Medical Technology Co., Ltd. develops, manufactures, and sells disposable and implantable medical devices. | Medical Specialties | Director/Board Member | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
SYNLOGIC, INC. | Biotechnology | Director/Board Member | |
Jian Rui Bao | Director/Board Member | ||
Yale School of Medicine | College/University | Corporate Officer/Principal | |
INC Research, Inc.
INC Research, Inc. Drugstore ChainsRetail Trade INC Research, Inc. provides therapeutically focused drug development services. It managing programs for pharmaceutical and biotech companies developing drugs in the complex areas of neurology, psychiatry, pain and cancer research. The firm also offer specialized pediatric drug development expertise across all therapeutic areas. The company is headquartered in San Diego, CA. | Drugstore Chains | Director/Board Member | |
ICOSAVAX, INC. | Pharmaceuticals: Major | Director/Board Member | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
Yale University | College/University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 38 |
Chine | 6 |
Canada | 4 |
Autriche | 2 |
Israël | 2 |
Sectorielle
Health Technology | 29 |
Consumer Services | 9 |
Commercial Services | 7 |
Finance | 5 |
Industrial Services | 2 |
Opérationnelle
Director/Board Member | 151 |
Corporate Officer/Principal | 49 |
Independent Dir/Board Member | 27 |
Chief Executive Officer | 17 |
Chairman | 15 |
Relations les plus connectées
Insiders | |
---|---|
Michael Ross | 44 |
Chau Khuong | 38 |
Chen-Ming Yu | 33 |
Daniel Burgess | 28 |
Douglas Reed | 27 |
Terry Gould | 26 |
Court Turner | 17 |
Jennifer Giottonini Cayer | 12 |
Eric Loumeau | 11 |
Elizabeth E. Morgan | 8 |
Scott J. Hecker | 7 |
Jeffery S. Loutit | 5 |
Olga Lomovskaya | 5 |
Jennifer Sanfilippo | 5 |
J.C. Lopez | 1 |
- Bourse
- Insiders
- Michael Dudley
- Connexions Sociétés